Addressing Conflicts of Interest in Orphan Drug Studies
Addressing Conflicts of Interest in Orphan Drug Studies Managing Conflicts of Interest in Orphan Drug Clinical Trials Understanding the Nature of Conflicts in Orphan Drug Research Orphan drug development offers unique opportunities—and unique challenges. Rare disease studies often receive special regulatory incentives, including market exclusivity, tax credits, and fast-track designations. While these policies accelerate innovation,…
Read More “Addressing Conflicts of Interest in Orphan Drug Studies” »